Gene: TMEM170B
Official Full Name: transmembrane protein 170Bprovided by HGNC
Gene Summary: Involved in negative regulation of canonical Wnt signaling pathway. Located in plasma membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13221 | TMEM170B Knockout cell line (HCT 116) | Human | TMEM170B | 1:2~1:4 | Negative | Online Inquiry |
KO13222 | TMEM170B Knockout cell line (HEK293) | Human | TMEM170B | 1:3~1:6 | Negative | Online Inquiry |
KO13223 | TMEM170B Knockout cell line (A549) | Human | TMEM170B | 1:3~1:4 | Negative | Online Inquiry |
TMEM170B Gene Knockout Cell Lines are specialized cellular models that have been genetically engineered to lack the expression of the TMEM170B gene, a member of the transmembrane protein family. This product serves as a vital tool for researchers delving into gene function, protein interactions, and cellular processes involving membrane proteins. The key function of these knockout cell lines lies in facilitating the investigation of TMEM170B's role in physiological and pathological contexts. By eliminating the gene's expression, researchers can study the resultant phenotypic changes and better understand the biological effects of TMEM170B, such as its involvement in cell signaling, metabolic regulation, and possibly its links to diseases.
The scientific importance of TMEM170B Gene Knockout Cell Lines extends to various research fields, including cancer biology, neurobiology, and immunology. In clinical settings, these cell lines can be utilized to assess drug responses and to develop novel therapeutic strategies targeting similar membrane proteins. The specific advantage of utilizing TMEM170B knockout lines over traditional methods, such as RNA interference, lies in their complete ablation of the target gene, thereby providing clearer and more interpretable results in functional studies.
For researchers and clinicians, these cell lines represent a cutting-edge resource that enhances experimental rigor and reproducibility. By offering a platform for elucidating the role of TMEM170B, users can drive forward innovations in biomedical research and translational science. Our company specializes in providing top-tier biological tools, and our expertise in creating validated knockout models ensures that users receive high-quality products tailored for robust scientific exploration and discovery.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.